Avoid common mistakes on your manuscript.
Oxygen, iron, and polyunsaturated fatty acids (PUFAs; fatty acids containing more than one double bond) are all beneficial to our cellular lives. Incorporation of these components into cellular processes, however, comes at a cost: the bis-allylic structure of PUFAs and the enrichment of cellular environments with iron and oxygen render PUFA-containing phospholipids (PUFA-PLs) particularly susceptible to peroxidation (Yang and Stockwell, 2016). Accumulation of lethal amounts of lipid peroxides in cell membranes leads to a form of cell death known as ferroptosis (Dixon et al., 2012; Stockwell et al., 2017; Stockwell and Jiang, 2020). Consequently, cells are equipped with strong antioxidant defense systems that constantly dissipate toxic lipid peroxides generated in cellular membranes, thereby maintaining cell viability and homeostasis (Zheng and Conrad, 2020). The most powerful anti-ferroptosis defense system is believed to be mediated by glutathione peroxidase 4 (GPX4), a glutathione peroxidase that uses glutathione as its cofactor to reduce lipid hydroperoxides to non-toxic lipid alcohols (Fig. 1) (Zheng and Conrad, 2020). A variety of ferroptosis inducers (FINs) act to inactivate GPX4 or deplete glutathione, causing an imbalance between the production and detoxification of lipid peroxides that subsequently induces ferroptotic cell death (Yang et al., 2014). Genetic ablation of GPX4 can have the same effect (Friedmann Angeli et al., 2014).
Exactly how lipid peroxidation occurs in PUFA-PLs is less well understood, but lipid peroxidation is known to involve both non-enzymatic reactions (e.g., autoxidation, which requires iron and oxygen) and protein enzymes (Yin et al., 2011; Conrad and Pratt, 2019). Enzymatic lipid peroxidation was initially thought to be carried out mostly by lipoxygenases (ALOXs) (Yang et al., 2016; Wenzel et al., 2017). However, several lines of evidence from recent studies argue against ALOXs being essential drivers of lipid peroxidation. First, the ALOX inhibitors that were used to establish the role of ALOX in regulating ferroptosis turned out to also harbor a previously unrecognized radical-trapping antioxidant activity (Shah et al., 2018). Therefore, whether these compounds block ferroptosis by inhibiting ALOXs or by trapping lipid peroxyl radicals remains unclear. Further, ALOXs are expressed in extremely low levels in most cancer cell lines (Zou et al., 2020b), raising further questions about its role in regulating ferroptosis in broad contexts. Finally, depleting ALOXs in cancer cells that already have low ALOX expression did not affect the cells’ sensitivity to ferroptosis (Zou et al., 2020b). These findings suggest that one or more additional enzymes exist to mediate lipid peroxidation, the identity of which was revealed in two recent studies (Yan et al., 2020; Zou et al., 2020b).
In both studies, CRISPR screening identified two genes, acyl-coenzyme A (CoA)-synthetase long-chain family member 4 (ACSL4) and cytochrome P450 reductase (POR), as top suppressor hits (whose inactivation suppressed FIN-induced ferroptosis, resulting in relative enrichment of their gRNAs in FIN-treated cells relative to that in control cells). ACSL4 is an acyl-CoA synthetase that converts free long-chain fatty acids into fatty acyl-CoA esters, with a preference for PUFAs. ACSL4 deficiency is known to compromise PUFA-PL biosynthesis, leading to remarkable ferroptosis resistance in cells (Dixon et al., 2015; Doll et al., 2017; Kagan et al., 2017). Therefore, the identification of ACSL4 as a top suppressor hit validated these CRISPR screens. However, the potential role of POR in ferroptosis had been previously unknown. POR deletion was subsequently confirmed to promote strong resistance to ferroptosis induced by different FINs and in a wide range of cancer cell lines. POR deficiency did not affect levels of GPX4 or its cofactor glutathione, binding between GPX4 and its inhibitors, or phospholipid profiles, but POR deficiency significantly reduced the levels of peroxidized PL species resulting from treatment with FINs, indicating that POR promotes lipid peroxidation during ferroptotic stress (Yan et al., 2020; Zou et al., 2020b). Notably, POR is expressed at high levels in most cancer cell lines (Zou et al., 2020b), supporting its role as a general driver of lipid peroxidation.
These findings prompt the question of how POR governs the production of lipid peroxides. POR is an oxidoreductase located in the endoplasmic reticulum that uses FAD and FMN as its cofactors to donate electrons from NADPH to cytochrome P450 (CYPs) as well as other proteins, and it participates in controlling xenobiotic detoxification and redox homeostasis (Pandey and Fluck, 2013). Re-expression of wild-type POR, but not its mutants with defective electron transfer activity, in POR-deficient cells restored ferroptosis sensitivity, indicating that the electron transfer activity of POR is required for its function in ferroptosis regulation (Yan et al., 2020). Zou et al. speculated that by donating electrons to CYPs, POR might facilitate Fenton reactions in the heme component of CYPs and thereby lipid peroxidation (because Fenton reactions are required for autoxidation during lipid peroxidation) (Zou et al., 2020b). Yan et al. showed that deletion of the transmembrane region in POR that mediates the interaction of POR with CYPs abolishes the ability of POR to donate electrons to CYPs, yet this mutant acts like its wild-type counterpart in terms of promoting lipid peroxidation and ferroptosis, indicating that POR regulates lipid peroxidation in a manner independent of CYPs (Yan et al., 2020). Further, deletion of other POR electron acceptor proteins, such as heme oxygenase, cytochrome squalene monooxygenase, or cytochrome b5, did not affect ferroptosis sensitivity, suggesting that these other proteins downstream of POR also do not mediate the function of POR in ferroptosis regulation (Yan et al., 2020). However, because there exist multiple CYP members and other proteins that can act as electron acceptors downstream of POR in a highly redundant manner, their roles in mediating POR’s function in regulating ferroptosis cannot be completely excluded and require further investigations (such as by compound knockout).
Noting that the ferroptosis-resistance phenotype in POR-deficient cells is milder than that in cells treated with ferroptosis inhibitors, Yan et al. reasoned that other oxidoreductases may operate in parallel with POR to mediate lipid peroxidation and ferroptosis. This led to the identification of NADH-cytochrome b5 reductase 1 (CYB5R1) as yet another oxidoreductase whose deficiency suppresses lipid peroxidation and ferroptosis, albeit with more moderate effects than POR inactivation; combined deficiency of both POR and CYB5R1 resulted in even more pronounced ferroptosis resistance than did deficiency of either gene alone (Yan et al., 2020). It is possible that CYB5R1 acts as a context-specific contributor to ferroptosis, and other unidentified oxidoreductases may be involved in regulating ferroptosis under other cellular contexts.
Because ferroptosis is a form of oxidative stress-induced cell death, and both POR and CYB5R1 have roles in redox regulation, Yan et al. further reasoned that POR and CYB5R1’s function in governing lipid peroxidation and ferroptosis could relate to their potential abilities to generate reactive oxygen species, likely through electron transfer. In support of this hypothesis, they showed that purified POR could produce H2O2 (but not superoxide) in an NADPH- and oxygen-dependent manner and that POR-deficient cells exhibit lower levels of intracellular H2O2 (Yan et al., 2020). CYB5R1 had similar, albeit more moderate effects, which is consistent with the effects of these two proteins in inducing lipid peroxidation and ferroptosis. Moreover, treatment with H2O2 re-sensitized POR-deficient cells (which are resistant to ferroptosis) to ferroptosis. This series of elegant experiments strongly suggests that POR (as well as CYB5R1) promotes lipid peroxidation and ferroptosis through the generation of H2O2 (Fig. 1). H2O2 can participate in lipid peroxidation probably through the following reactions (Conrad and Pratt, 2019): H2O2 is first converted to hydroxyl radicals (•OH) via its reaction with Fe2+. The •OH can subsequently abstract a hydrogen from the bis-allylic moieties in PUFA-PLs, resulting in PUFA-PL radicals (•PUFA-PLs), which then react with oxygen to produce PUFA-PL peroxyl radicals (•OO-PUFA-PLs) and PUFA-PL hydroperoxides (HOO-PUFA-PLs) (Fig. 1).
Exactly how lipid peroxidation eventually triggers ferroptotic cell death remains a central question (Stockwell et al., 2020). Thus far, two non-mutually exclusive models have been developed to address this question. In one model, lipid peroxidation is thought to damage cellular membranes directly, leading to membrane rupture and cell demise; in the other model, lipid peroxidation is thought to trigger downstream signaling events culminating in the activation of a cell-death “executioner” that can perforate cellular membranes and kill cells, much like MLKL in necroptosis or gasdermins in pyroptosis (Galluzzi et al., 2018). (This latter model would predict that, unlike ACSL4 or POR deficiency, inactivation of such a ferroptosis executioner should not affect FIN-induced lipid peroxidation but would still drive ferroptosis resistance, thereby uncoupling lipid peroxidation from ferroptotic cell death. However, no gene with this characteristic has been identified so far.) In a remarkable experiment, Yan and colleagues demonstrated that purified recombinant POR, together with iron and NADPH, caused significant leakage from PUFA-containing liposomes in a cell-free system, accompanied by liposomal rupture; this POR-induced liposome leakage could be rescued by treatment with a ferroptosis inhibitor (Yan et al., 2020). These analyses provide compelling evidence that POR-catalyzed lipid peroxidation is sufficient to induce membrane rupture.
To place their findings in the context of ferroptosis-associated diseases, Yan et al. studied the potential role of POR in Concanavalin A (ConA)-induced acute liver injury, which has been causally linked with ferroptosis (Zeng et al., 2020). POR depletion in mouse liver markedly suppressed ConA-induced liver damage and animal lethality; likewise, ConA treatment induced higher levels of the ferroptosis markers PTGS2 and malondialdehydes in mouse liver, whereas POR depletion attenuated these ConA-induced ferroptosis markers, indicating that POR is required for ConA-induced acute liver injury, probably by inducing lipid peroxidation and ferroptosis in vivo (Yan et al., 2020).
Yan et al. further suggested that POR could be considered an “executioner” for ferroptosis, as it likely to be the protein involved in the final step in triggering ferroptotic cell death. It should be noted that there are several notable differences between POR and other classic cell death executioners such as MLKL and gasdermins. First, unlike MLKL and gasdermins, POR does not have the pore-forming activity. In addition, cell death modalities, such as apoptosis, necroptosis, and pyroptosis, are considered cell “suicide” programs that utilize evolutionarily conserved developmental pathways to actively clear unwanted cells in an organism and are triggered by dedicated cell death executioner proteins, whose activation is often governed by upstream signaling. In contrast, ferroptosis is viewed as a cell “sabotage” program, wherein the cell death results from metabolic imbalance that goes beyond the control of cellular antioxidant buffering systems (Green and Victor, 2012). As such, it appears that the pro-ferroptosis factors identified so far are not proteins dedicated in cell death regulation, but rather those incidentally involved in generating ferroptosis-triggering metabolites in a constitutive fashion. For example, ACSL4’s professional function is to regulate PUFA-PL biosynthesis. Because PUFA-PLs are susceptible to peroxidation, ACSL4 appears to participate in ferroptosis induction in a more “incidental” manner. The same principle can be applied to the role of POR in triggering ferroptosis. For these considerations, whether POR can be classified as a cell death executioner is certainly debatable.
Together, these two recent studies identified POR as a key player to “fuel” ferroptosis. Mechanistically, POR (and CYB5R1) can transfer electrons from NAD(P)H to oxygen to produce H2O2, which then drives lipid peroxidation, membrane rupture, and ferroptosis (Fig. 1). These intriguing studies also raised several important questions. The exact roles of H2O2 (and metabolic enzymes involved in H2O2 production or detoxification) in ferroptosis regulation remain to be further studied. A previous study showed that replacement of the selenocysteine residue in GPX4 with cysteine (GPX4cys/cys mutant) rendered cells exquisitely sensitive to H2O2-induced cell death; interestingly, while H2O2-induced cell death in GPX4cys/cys cells could be rescued by ferroptosis inhibitors, these inhibitors failed to rescue cell death induced by H2O2 at much higher concentrations in wild-type counterparts (Ingold et al., 2018). Therefore, it appears that H2O2 induces ferroptosis in a context- and dose-dependent manner. Further, while overexpression of a genetically engineered cytosol-localized catalase (an enzyme that normally localizes in peroxisomes and catalyzes H2O2 decomposition in peroxisomes) in POR-proficient cells promoted ferroptosis resistance (Yan et al., 2020), another recent study showed that deleting endogenous catalase (and thereby abolishing H2O2 decomposition in peroxisomes) did not affect ferroptosis sensitivity in other cancer cell lines (Zou et al., 2020a), suggesting a cellular compartment- or cell line-dependent role of catalase in ferroptosis protection. The exact role of catalase in ferroptosis protection therefore remains to be studied in broader contexts. Finally, given the association of ferroptosis with diverse diseases and conditions such as cancer, ischemia/reperfusion-induced organ damage, and degenerative diseases (Gao et al., 2015; Jiang et al., 2015; Stockwell et al., 2017; Zhang et al., 2018; Lee et al., 2020; Zheng and Conrad, 2020), future investigations should also be directed to understanding the role of POR in these other ferroptosis-associated diseases and the potential applications of POR inhibitors for treating diseases caused by excessive ferroptosis.
References
Conrad M, Pratt DA (2019) The chemical basis of ferroptosis. Nat Chem Biol 15:1137–1147
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060–1072
Dixon SJ, Winter GE, Musavi LS, Lee ED, Snijder B, Rebsamen M, Superti-Furga G, Stockwell BR (2015) Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem Biol 10:1604–1609
Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A et al (2017) ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 13:91–98
Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch A, Eggenhofer E et al (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16:1180–1191
Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW et al (2018) Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 25:486–541
Gao M, Monian P, Quadri N, Ramasamy R, Jiang X (2015) Glutaminolysis and transferrin regulate ferroptosis. Mol Cell 59:298–308
Green DR, Victor B (2012) The pantheon of the fallen: why are there so many forms of cell death? Trends Cell Biol 22:555–556
Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, Roveri A, Peng X, Porto Freitas F, Seibt T et al (2018) Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell 172(409–422):e421
Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R, Gu W (2015) Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520:57–62
Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB et al (2017) Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol 13:81–90
Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, Tyagi S, Ma L, Westbrook TF, Steinberg GR et al (2020) Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol 22:225–234
Pandey AV, Fluck CE (2013) NADPH P450 oxidoreductase: structure, function, and pathology of diseases. Pharmacol Ther 138:229–254
Shah R, Shchepinov MS, Pratt DA (2018) Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Cent Sci 4:387–396
Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascon S, Hatzios SK, Kagan VE et al (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:273–285
Stockwell BR, Jiang X (2020) The chemistry and biology of ferroptosis. Cell Chem Biol 27:365–375
Stockwell BR, Jiang X, Gu W (2020) Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol 30:478–490
Wenzel SE, Tyurina YY, Zhao J, St Croix CM, Dar HH, Mao G, Tyurin VA, Anthonymuthu TS, Kapralov AA, Amoscato AA et al (2017) PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell 171(628–641):e626
Yan B, Ai Y, Sun Q, Ma Y, Cao Y, Wang J, Zhang Z, Wang X (2020) Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell
Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR (2016) Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA 113:E4966–E4975
Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156:317–331
Yang WS, Stockwell BR (2016) Ferroptosis: death by lipid peroxidation. Trends Cell Biol 26:165–176
Yin H, Xu L, Porter NA (2011) Free radical lipid peroxidation: mechanisms and analysis. Chem Rev 111:5944–5972
Zeng T, Deng G, Zhong W, Gao Z, Ma S, Mo C, Li Y, Huang S, Zhou C, Lai Y et al (2020) Indoleamine 2, 3-dioxygenase 1enhanceshepatocytes ferroptosis in acute immune hepatitis associated with excess nitrative stress. Free Radic Biol Med 152:668–679
Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, Sirohi K, Li X, Wei Y, Lee H et al (2018) BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol 20:1181–1192
Zheng J, Conrad M (2020) The metabolic underpinnings of ferroptosis. Cell Metab 32:920–937
Zou Y, Henry WS, Ricq EL, Graham ET, Phadnis VV, Maretich P, Paradkar S, Boehnke N, Deik AA, Reinhardt F et al (2020a) Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature 585:603–608
Zou Y, Li H, Graham ET, Deik AA, Eaton JK, Wang W, Sandoval-Gomez G, Clish CB, Doench JG, Schreiber SL (2020b) Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol 16:302–309
Acknowledgements
We thank Christine Wogan for editing the manuscript, and apologize to the colleagues whose relevant work cannot be cited here due to space limitations. Research in the authors’ lab has been supported by The University of Texas MD Anderson Cancer Center, National Institutes of Health grants R01CA181196, R01CA190370, R01CA244144, and R01CA247992 (to BG), a CPRIT Research Training Grant (RP170067), and the Dr. John J. Kopchick Research Award from The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (to PK). This work was also supported in part by Cancer Center Support (Core) Grant P30 CA016672 from the National Cancer Institute, to The University of Texas MD Anderson Cancer Center.
Funding
BG is supported by The University of Texas MD Anderson Cancer Center, National Institutes of Health grants R01CA181196, R01CA190370, R01CA244144, and R01CA247992, and Cancer Center Support (Core) Grant P30 CA016672 from the National Cancer Institute, National Institutes of Health, to The University of Texas MD Anderson Cancer Center. PK is supported by a CPRIT Research Training Grant (RP170067), and the Dr. John J. Kopchick Research Award from The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences.
Conflicts of interest/Competing interests
Pranavi Koppula, Li Zhuang, and Boyi Gan declare that they have no conflict of interest.
Ethics approval
Not applicable.
Consent to participate
Not applicable. This article does not contain any studies with human or animal subjects performed by the any of the authors.
Consent for publication
Not applicable.
Availability of data and material
Not applicable.
Code availability
Not applicable.
Authors’ contributions
BG wrote the manuscript with additional support from LZ. PK generated the figure.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Koppula, P., Zhuang, L. & Gan, B. Cytochrome P450 reductase (POR) as a ferroptosis fuel. Protein Cell 12, 675–679 (2021). https://doi.org/10.1007/s13238-021-00823-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13238-021-00823-0